NCT04390776View on ClinicalTrials.gov

Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.

PHASE1CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

July 19, 2021

Study Completion Date

July 19, 2021

Conditions
Healthy Participants
Interventions
DRUG

PF-06651600

PF-06651600 100 milligrams (mg) will be provided as Tablets and Capsules.

Trial Locations (2)

33024

Research Centers of America ( Hollywood ), Hollywood

55114

Prism Research LLC dba Nucleus Network, Saint Paul

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04390776 - Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules. | Biotech Hunter | Biotech Hunter